Uni Research   Report issue

For profit Phase 1 Phase 3
Founded: Bergen Norway (2003)

Organization Overview

First Clinical Trial
2008
NCT00463970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

GAMUT, Uni Research Health, Bergen, Norway | Uni Research

Active Ingredients

Drugs in Phase 3 Trials (1)

cobalamin (1 trial)

Drugs in Phase 1 Trials (1)

seal oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 1)

Low Back Pain (Phase 1)

Vitamin B 12 Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2